as on November 3, 2025 at 4:01 pm IST
Day's Low
Day's High
0.22%
Downside
1.13%
Upside
52 Week's Low
52 Week's High
32.77%
Downside
21.31%
Upside
as on November 3, 2025 at 4:01 pm IST
Market Cap
₹754.78 Cr
Return on Equity (ROE)
0.64
PE Ratio (TTM)
3.07
Return on capital employed (ROCE)
1.09
Industry PE ratio
41.96
Beta (LTM)
0.72
P/B Ratio
0.53
Dividend Yield
0PEG Ratio
-0.05
Quarterly Earnings Growth YOY
756.44
EPS (TTM)
36.44
Sector
Pharmaceuticals
Book Value
159.86
Technical Analysis
Bearish
View Technical Analysis
as on November 3, 2025 at 4:01 pm IST
Ind-Swift Laboratories Ltd in the last 5 years
Lowest (-1795.00x)
December 8, 2022
Today (3.07x)
October 31, 2025
Industry (41.96x)
October 31, 2025
Highest (64.97x)
July 19, 2021
Today’s Price to Earnings Ratio: 3.07x
Compare market cap, revenue, PE, and other key metrics of Ind-Swift Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 754.78 | 22.49% | 0.52 | 250 | 561 | |
| NA | 146.09 | -7.9% | 0.00 | 13 | 103 | |
| NA | 916.74 | 134.62% | 0.88 | 30 | 599 | |
| NA | 5,067.97 | 264.2% | 0.00 | 48 | 150 | |
| NA | 14.67 | 65.11% | 0.00 | -1 | NA |
Search interest for Ind-Swift Laboratories Ltd Stock has increased by 18% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:18% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Ind-Swift Laboratories Ltd.
Ind-Swift Laboratories Ltd’s net profit jumped 832.98% since last year same period to ₹8.77Cr in the Q1 2025-2026. On a quarterly growth basis, Ind-Swift Laboratories Ltd has generated -96.05% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2011, Ind-Swift Laboratories Ltd has declared dividend of ₹1.00 per share on 25 May 2011 - translating a dividend yield of 1.95%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
![]()
Retail Investor have increased holdings from 44.92% to 45.02% in Sep 2025 quarter
Price Rise
![]()
In the last 6 months, INDSWFTLAB stock has moved up by 34.7%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 39.50% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Divis Laboratories Ltd has given 14.2% return, outperforming this stock by 26.8%
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 110.7% return, outperforming this stock by 19.4%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 222.27 Cr → 8.77 Cr (in ₹), with an average decrease of 96.1% per quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 358.57 Cr → 167.32 Cr (in ₹), with an average decrease of 53.3% per quarter
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 14.91% to 14.80% in Sep 2025 quarter
| Organisation | Ind-Swift Laboratories Ltd |
| Headquarters | Chandigarh |
| Industry | Pharmaceuticals |
| CEO | N R Munjal |
| E-voting on shares | Click here to vote |
Ind-Swift Laboratories Ltd share price today stands at ₹102.22 as on at the close of the market. Ind-Swift Laboratories Ltd share today touched a day high of ₹103.37 and a low of ₹102.
Ind-Swift Laboratories Ltd touched a 52 week high of ₹124 and a 52 week low of ₹68.72. Ind-Swift Laboratories Ltd share price today i.e. is closed at ₹102.22, which is -17.56% down from its 52 week high and 48.75% up from its 52 week low.
Ind-Swift Laboratories Ltd market capitalisation is ₹754.78 Cr as on .
To buy Ind-Swift Laboratories Ltd shares, you need to follow these steps:
Ind-Swift Laboratories Ltd trading volume is 41.66K as on . This means that 41.66K shares of Ind-Swift Laboratories Ltd were bought and sold on the stock market during today's trading session.